AYTU
Aytu BioPharma, Inc.
Drug Manufacturers - Specialty & Generic · Healthcare · United States
1.98
close · 2026-10-29
value
88
cheaper than peers88
quality
6
stronger fundamentals6
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
41 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.60× | 99 |
| price to sales | 0.44× | 96 |
| forward P/E | 12.77× | 39 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 65.3% | 56 |
| operating margin | -32.7% | 16 |
| return on equity | -97.4% | 13 |
| revenue growth | -32.7% | 9 |
4 of 4 measures available
Facts
| market cap | $22M |
| free cash flow | -$1.2M |
| employees | 82 |
| first trade | 2008-09-25 |
| next earnings | not reported |
| fundamentals updated | 2026-08-13 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.16 | -2.86 | -5.11 | -75.00 |
| free cash flow | -$5.2M | -$1.7M | -$5.1M | -$28.8M |
| net income | -$13.6M | -$15.8M | -$17.1M | -$108.8M |
| revenue | $66.4M | $65.2M | $107.4M | $96.7M |
| unusual items | -$12.1M | -$6.8M | $57,000 | -$72.0M |